Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Influence of BCR-ABL Transcript Type on Outcome in Patients with Chronic-Phase Chronic Myeloid Leukemia Treated with Imatinib 400 Mg

Katia B.B. Pagnano, MD PhD, Eliana Cristina Martins Miranda, PhD, Marcia T Delamain, MD, Gislaine OLIVEIRA Duarte, MD, Erich Vinicius De Paula, MD PhD, Valquiria Povoa, Bruna Rocha Vergilio, Irene Lorand-Metze, MD PhD, Carmino Antônio De Souza, MD PhD

Blood (2016) 128 (22): 1911.

https://doi.org/10.1182/blood.V128.22.1911.1911

Published: 2016

Journal Articles

Assessment of Cardiovascular Events in Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors

Katia B.B. Pagnano, MD PhD, Paola Morelato Assunção, MD, Roberto Zullli, Marcia T Delamain, MD, Gislaine OLIVEIRA Duarte, Irene Lorand-Metze, MD PhD, Carmino A De Souza, Sr., MD PhD

Blood (2015) 126 (23): 4031.

https://doi.org/10.1182/blood.V126.23.4031.4031

Published: 2015

Journal Articles

Gene Expression Profile in Responsive and Non-Responsive Chronic Myeloid Leukemia Patients Treated with Dasatinib.

Rosana A Silveira, MSc, Angela A Fachel, Yuri B Moreira, Marcia T Delamain, MD, Carmino Antonio De Souza, MD, PhD, Fernando Ferreira Costa, Ph.D., M.D., Sergio Verjovski-Almeida, MD, PhD, Katia B.B. Pagnano, MD, PhD

Blood (2009) 114 (22): 3260.

https://doi.org/10.1182/blood.V114.22.3260.3260

Published: 2009

Journal Articles

Brazilian Experience Using High Dose Sequential (HDS) Followed by Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Relapse/Refractory Aggressive Non-Hodgkin Lymphoma (NHL).

Bruno K.L. Duarte, MD, I.S. Valente, MD, Afonso C. Vigorito, MD, Francisco J.P. Aranha, MD, Gislaine B. Oliveria, MD, Eliana C.M. Miranda, Irene Lorand-Metze, PhD, Katia B.B. Pagnano, MD, Carmino A. De Souza, MD, PhD

Blood (2007) 110 (11): 5102.

https://doi.org/10.1182/blood.V110.11.5102.5102

Published: 2007

Journal Articles

High Dose Sequential (HDS) Followed by Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Salvage Treatment of Hodgkin’s Disease (HD): A Brazilian Experience.

Bruno K.L. Duarte, MD, I.S. Valente, MD, Afonso C. Vigorito, MD, Francisco J.P. Aranha, MD, Gislaine B. Oliveira, MD, Eliana C.M. Miranda, Irene Lorand-Metze, PhD, Katia B.B. Pagnano, MD, Carmino A. De Souza, MD, PhD

Blood (2007) 110 (11): 5103.

https://doi.org/10.1182/blood.V110.11.5103.5103

Published: 2007

Journal Articles

Janus Kinase (JAK2) V617F Somatic Mutation in Patients with Deep Vein Thrombosis.

Fernanda A. Orsi, Devanira S.P. Costa, Katia B.B. Pagnano, Joyce M. Annichino-Bizzachi

Blood (2007) 110 (11): 1645.

https://doi.org/10.1182/blood.V110.11.1645.1645

Published: 2007

Journal Articles

Screening of Mutations in BCR-ABL Kinase Domain in Chronic Myeloid Leukemia (CML) Patients Treated with Kinase Inhibitors by Denaturing High-Performance Liquid Chromatography (D-HPLC).

Cintia C. Mascarenhas, Anderson F. Cunha, Katia B.B. Pagnano, MD, Rosana A. Silveira, Fernando F. Costa, MDPhD, Ricardo Pasquini, MDPhD, Nelma C.D. Clementino, MDPhD, Carmino A. De Souza, MDPhD

Blood (2007) 110 (11): 4580.

https://doi.org/10.1182/blood.V110.11.4580.4580

Published: 2007

Journal Articles

Detection of BCR-ABL Point Mutations in Patients with Chronic Myeloid Leukemia (CML) Resistant to Imatinib.

Rosana A. Silveira, Dulcineia M. Albuquerque, PhD, Angela M. Assis, Edson Ichihara, Carmino A. de Souza, MD,PhD, Fernando F. Costa, MD,PhD, Marcia T. Delamain, MD, Afonso C. Vigorito, MD,PhD, Irene Lorand-Metze, MD,PhD, Eliana Miranda, Katia B.B. Pagnano, MD,PhD

Blood (2006) 108 (11): 4817.

https://doi.org/10.1182/blood.V108.11.4817.4817

Published: 2006

Journal Articles

High Frequency of Point Mutations of BCR/ABL Gene in CML Patients Resistant to Imatinib Therapy - Report of a Novel Mutation.

Edson Ichihara, Fernando F. Costa, MD, Natasha Busoli, Dulcineia M. Albuquerque, Irene Lorand-Metze, MD, Sara T.O. Saad, MD, Carmino A. De Souza, MD, Afonso C. Vigorito, MD, Katia B.B. Pagnano, MD

Blood (2004) 104 (11): 4661.

https://doi.org/10.1182/blood.V104.11.4661.4661

Published: 2004

NARROW

Influence of BCR-ABL Transcript Type on Outcome in Patients with Chronic-Phase Chronic Myeloid Leukemia Treated with Imatinib 400 Mg

Assessment of Cardiovascular Events in Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors

Gene Expression Profile in Responsive and Non-Responsive Chronic Myeloid Leukemia Patients Treated with Dasatinib.

Brazilian Experience Using High Dose Sequential (HDS) Followed by Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Relapse/Refractory Aggressive Non-Hodgkin Lymphoma (NHL).

High Dose Sequential (HDS) Followed by Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Salvage Treatment of Hodgkin’s Disease (HD): A Brazilian Experience.

Janus Kinase (JAK2) V617F Somatic Mutation in Patients with Deep Vein Thrombosis.

Screening of Mutations in BCR-ABL Kinase Domain in Chronic Myeloid Leukemia (CML) Patients Treated with Kinase Inhibitors by Denaturing High-Performance Liquid Chromatography (D-HPLC).

Detection of BCR-ABL Point Mutations in Patients with Chronic Myeloid Leukemia (CML) Resistant to Imatinib.

High Frequency of Point Mutations of BCR/ABL Gene in CML Patients Resistant to Imatinib Therapy - Report of a Novel Mutation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only